The global blood disorders testing market is exhibiting significant increase, propelled by a rising prevalence of leukemia and other related conditions. Researchers estimate the current market value to be substantial, with projections indicating a steady compound annual growth percentage (CAGR) over the projected period. Key trends shaping the indu